Apogee Therapeutics
APGE
APGE
139 hedge funds and large institutions have $2.13B invested in Apogee Therapeutics in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
39% less capital invested
Capital invested by funds: $3.52B → $2.13B (-$1.39B)
64% less funds holding in top 10
Funds holding in top 10: 11 → 4 (-7)
87% less call options, than puts
Call options by funds: $87K | Put options by funds: $652K
Holders
139
Holding in Top 10
4
Calls
$87K
Puts
$652K
Top Buyers
| 1 | +$50.3M | |
| 2 | +$30M | |
| 3 | +$21.6M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$15.2M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$9.84M |
Top Sellers
| 1 | -$55.3M | |
| 2 | -$52.1M | |
| 3 | -$26.6M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$20.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.8M |